Pyrimidine compounds
US7432260B2 · kind B2 · utility
10Cited by
1References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2004 |
| Grant date | Oct 7, 2008 |
| Priority date | — |
| Expiry date | Apr 17, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted pyrimidines of formula I, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders and/or viral disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.